OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Gary Gibson

3 Projects | 1 Researchers | $830,000 Invested

2016

Winifred Masterson Burke Medical Research Institute

Gary Gibson, PhD

Benfotiamine in Alzheimer's Disease: A Pilot Study

  • Funding Amount: $250,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Mitochondria/Metabolic Function
  • Status: Closed

2014

Winifred Masterson Burke Medical Research Institute

Gary Gibson, PhD

Benfotiamine in Alzheimer's Disease: A pilot study

  • Funding Amount: $500,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Status: Closed

2006

Weill Medical College of Cornell University

Gary Gibson, PhD

Tests of therapies aimed at mitochondrial deficits in neurodegenerative diseases

  • Funding Amount: $80,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed